{"schema_version":"1","generated_at":"2026-11-03T09:27:06.072Z","data_as_of":"2026-11-02","url":"https://www.findmykol.com/kol/joseph-lim","json_url":"https://www.findmykol.com/kol/joseph-lim/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"joseph-lim","name":"Joseph Lim","credential":"MD","title":"Professor of Medicine","specialty":"Gastroenterology","specialty_raw":"Gastroenterology","therapeutic_area":"Gastroenterology","therapeutic_areas":["Gastroenterology"],"institution":"Yale School of Medicine","institution_url":"https://www.findmykol.com/institution/yale-school-of-medicine","city":"New Haven","state":"CT","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1235112533","orcid":"0000-0003-1126-8128","openalex":"A5008472753"},"summary":"Joseph Lim is Professor of Medicine at Yale School of Medicine. OpenAlex indexes 398 publications with 22,792 citations (h-index 65); ClinicalTrials.gov lists 3 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Gastroenterology profiles in the FindMyKOL directory.","overview":{"text":"Joseph Lim, MD, is Professor of Medicine at Yale School of Medicine. The public record shows 398 publications with 22,792 citations (h-index 65), centered on Hepatitis C virus research, Liver Disease Diagnosis and Treatment, Hepatitis B Virus Studies. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 5 companies, 1 NIH-funded awards (2006–2006).","bullets":["Most recent indexed publication: 2026 · Translational gastroenterology and hepatology","Top research focus: Hepatitis C virus research","3 registered trials on ClinicalTrials.gov","Open Payments reporting from 5 companies"],"generated_at":"2026-11-03"},"focus":{"indications":[{"label":"Viral Hepatitis (B/C)","therapeutic_area":"Gastroenterology","trials":2,"topics":1,"strength":7},{"label":"Hepatitis C","therapeutic_area":"Infectious Disease","trials":2,"topics":0,"strength":6},{"label":"Hepatitis C, Chronic","therapeutic_area":"Infectious Disease","trials":2,"topics":0,"strength":6},{"label":"Hepatitis, Chronic","therapeutic_area":"Gastroenterology","trials":2,"topics":0,"strength":6},{"label":"Hypertension","therapeutic_area":"Cardiology","trials":1,"topics":0,"strength":3},{"label":"Hemorrhage","therapeutic_area":"Hematology","trials":1,"topics":0,"strength":3},{"label":"Hypertension, Portal","therapeutic_area":"Gastroenterology","trials":1,"topics":0,"strength":3},{"label":"Varicose Veins","therapeutic_area":"Cardiology","trials":1,"topics":0,"strength":3},{"label":"Esophageal and Gastric Varices","therapeutic_area":"Gastroenterology","trials":1,"topics":0,"strength":3}],"research_topics":["Hepatitis C virus research","Liver Disease Diagnosis and Treatment","Hepatitis B Virus Studies","Liver Disease and Transplantation","Animal Virus Infections Studies"],"works_with":{"total":7,"shown":3,"withheld":4,"rows":[{"name":"Davol Inc.","trials":0,"payments":6,"mentions":6},{"name":"Eli Lilly and Company","trials":0,"payments":2,"mentions":2},{"name":"Romark Laboratories L.C.","trials":2,"payments":0,"mentions":2}]}},"scholarship":{"works_count":398,"cited_by_count":22792,"h_index":65,"i10_index":166,"pubmed_count":21,"latest_activity_year":2026,"citation_standing":{"top_percent":5,"cohort":"Gastroenterology","method":"https://www.findmykol.com/about#citation-standing"},"source":"works"},"trials":{"count":3,"shown":3,"withheld":0,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT00637923","title":"Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Hepatitis C Patients","phase":"PHASE2","status":"COMPLETED","role":"Investigator","sponsor":"Romark Laboratories L.C.","source_url":"https://clinicaltrials.gov/study/NCT00637923","trial_url":"https://www.findmykol.com/trial/NCT00637923"},{"nct":"NCT00495391","title":"Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin for the Treatment of Hepatitis C","phase":"PHASE2","status":"COMPLETED","role":"Investigator","sponsor":"Romark Laboratories L.C.","source_url":"https://clinicaltrials.gov/study/NCT00495391","trial_url":"https://www.findmykol.com/trial/NCT00495391"},{"nct":"NCT00331188","title":"Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal Bleeding","phase":"PHASE3","status":"COMPLETED","role":"Investigator","sponsor":"Debiovision","source_url":"https://clinicaltrials.gov/study/NCT00331188","trial_url":"https://www.findmykol.com/trial/NCT00331188"}],"source":"trials"},"payments":{"company_count":5,"program_years":{"first":2021,"last":2024},"rows_total":5,"shown":3,"withheld":2,"rows":[{"payer":"Davol Inc.","program_year":2024,"amount_usd":296.26,"payment_count":6,"source_url":"https://openpaymentsdata.cms.gov/search?query=1235112533"},{"payer":"Eli Lilly and Company","program_year":2021,"amount_usd":7208,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1235112533"},{"payer":"Gilead Sciences, Inc.","program_year":2021,"amount_usd":5000,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1235112533"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1235112533","source":"payments"},"prescribing":{"data_year":2024,"areas_total":2,"areas_shown":2,"areas":[{"area":"Anti-infectives","share_pct":77.3,"classes_total":2,"classes":[{"class":"Nucleoside and nucleotide reverse transcriptase inhibitors","setting":"prescribed","share_pct":61.9,"drugs":[{"name":"Vemlidy","share_pct":100}],"max_beneficiaries":null},{"class":"Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor","setting":"prescribed","share_pct":15.5,"drugs":[{"name":"Entecavir","share_pct":100}],"max_beneficiaries":null}]},{"area":"Metabolism & gastrointestinal","share_pct":22.7,"classes_total":1,"classes":[{"class":"Bile Acid","setting":"prescribed","share_pct":22.7,"drugs":[{"name":"Ursodiol","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"mixed","data_year":2024,"office_pct":46.9,"facility_pct":53.1},"source":"medicare"},"funding":{"award_count":1,"fiscal_years":{"first":2006,"last":2006},"rows_total":1,"shown":1,"withheld":0,"rows":[{"project":"R21AA015894","title":"Markers of Alcohol Toxicity in HIV-infected Veterans","fiscal_year":2006,"amount_usd":183045,"organization":"YALE UNIVERSITY","source_url":"https://reporter.nih.gov/quickSearch/R21AA015894"}],"source":"grants"},"congress":{"count":2,"years":{"first":2016,"last":2019},"societies":["AACR","ASCO"],"shown":2,"withheld":0,"rows":[{"title":"Impact of direct-acting antivirals and 12-week sustained viral response on clinical outcomes in patients with hepatitis C and hepatocellular carcinoma.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2019,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco.2019.37.4_suppl.397","source_url":"https://doi.org/10.1200/jco.2019.37.4_suppl.397","status":"verified"},{"title":"Abstract 4308: Multiplicative interaction between HIV infection status and FIB-4 in prediction of hepatocellular carcinoma risk","society":"AACR","meeting":"AACR (meeting unresolved)","year":2016,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1158/1538-7445.am2016-4308","source_url":"https://doi.org/10.1158/1538-7445.am2016-4308","status":"verified"}],"source":"congress"},"publications":{"total":21,"shown":5,"withheld":16,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"Combination therapeutics for hepatitis delta virus infection: implications of the tobevibart-elebsiran SOLSTICE phase 2 trial.","year":2026,"journal":"Translational gastroenterology and hepatology","types":["Editorial","Comment"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42592408/","status":"verified"},{"title":"AASLD ISDA Practice Guideline on treatment of chronic hepatitis B.","year":2026,"journal":"Hepatology (Baltimore, Md.)","types":["Journal Article","Practice Guideline"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/41186418/","status":"verified"},{"title":"Associations Between Prior and Current Unhealthy Alcohol Use and Liver Morbidity Risk and Mortality Among Veterans With a History of Hepatitis C Who Have Achieved Sustained Virological Response.","year":2026,"journal":"Journal of viral hepatitis","types":["Journal Article","Research Support, N.I.H., Extramural"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/41376520/","status":"verified"},{"title":"Advanced Liver Fibrosis Predicts Liver Outcomes in Biopsy-proven Metabolic Dysfunction-associated Steatotic Liver Disease: A U.S.-based Single-center Retrospective Cohort Study.","year":2024,"journal":"Journal of clinical and translational hepatology","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/39649030/","status":"verified"},{"title":"Outcomes of a 1-Year Pilot Study Implementing Universal Hepatitis Delta Virus Testing Among Veterans With Chronic Hepatitis B.","year":2024,"journal":"Journal of viral hepatitis","types":["Journal Article","Research Support, Non-U.S. Gov't"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/39101377/","status":"verified"}],"most_cited":{"total":398,"shown":5,"withheld":393,"rows":[{"title":"Longitudinal analyses reveal immunological misfiring in severe COVID-19","year":2020,"cited_by_count":2072,"type":"article","source_url":"https://doi.org/10.1038/s41586-020-2588-y"},{"title":"Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial","year":2019,"cited_by_count":1278,"type":"article","source_url":"https://doi.org/10.1016/s0140-6736(19)33041-7"},{"title":"ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries","year":2016,"cited_by_count":1224,"type":"article","source_url":"https://doi.org/10.1038/ajg.2016.517"},{"title":"American Gastroenterological Association Institute Guideline on the Diagnosis and Management of Asymptomatic Neoplastic Pancreatic Cysts","year":2015,"cited_by_count":1139,"type":"article","source_url":"https://doi.org/10.1053/j.gastro.2015.01.015"},{"title":"Diverse functional autoantibodies in patients with COVID-19","year":2021,"cited_by_count":999,"type":"article","source_url":"https://doi.org/10.1038/s41586-021-03631-y"}]},"source":"publications"},"network":{"coauthors_total":40,"shown":3,"withheld":37,"coauthors":[{"name":"Amy C. Justice","coauthored_works":45},{"name":"Mindie H. Nguyen","coauthored_works":43},{"name":"Vincent Lo Re","coauthored_works":42}],"source":"works"},"presence":{"mentions":{"total":4,"shown":3,"rows":[{"url":"https://cm.ynhh.org/physicians/joseph-lim","platform":"other","status":"provisional"},{"url":"https://gastro.org/aga-leadership/council-and-sections/liver-biliary/","platform":"other","status":"provisional"},{"url":"https://medicine.yale.edu/news-article/dr-joseph-k-lim-named-editor-in-chief-of-clinical-liver-disease/","platform":"other","status":"provisional"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"recognition":{"education":{"total":1,"shown":1,"rows":[{"value":"MD, Northwestern University Medical School (1999)","source_url":"https://medicine.yale.edu/profile/joseph-lim/","status":"verified","collected_at":"2026-11-03"}]},"roles":{"total":8,"shown":3,"rows":[{"value":"Editor-in-Chief of Clinical Liver Disease, appointment beginning January 2024","source_url":"https://medicine.yale.edu/news-article/dr-joseph-k-lim-named-editor-in-chief-of-clinical-liver-disease/","status":"verified","collected_at":"2026-11-03"},{"value":"Vice Chair, AGA Liver & Biliary council and section","source_url":"https://gastro.org/aga-leadership/council-and-sections/liver-biliary/","status":"provisional","collected_at":"2026-11-03"},{"value":"Committee member, Viral Hepatitis (CLDF Committees)","source_url":"https://www.chronicliverdisease.org/committees","status":"provisional","collected_at":"2026-11-03"}]},"secondary_affiliations":{"total":4,"shown":3,"rows":[{"value":"Yale Liver Center","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12968568/","status":"provisional","collected_at":"2026-11-03"},{"value":"Yale New Haven Health System","source_url":"https://medicine.yale.edu/profile/joseph-lim/","status":"verified","collected_at":"2026-11-03"},{"value":"Center for Interdisciplinary Research on AIDS","source_url":"https://medicine.yale.edu/profile/joseph-lim/","status":"verified","collected_at":"2026-11-03"}]},"media":{"total":5,"shown":3,"rows":[{"value":"Podcast guest, Small Talk, Big Topics (episode on guideline development)","source_url":"https://podcasts.apple.com/us/podcast/shahnaz-sultan-and-joseph-lim-inside-the/id1538056693?i=1000509234218&uo=4","status":"provisional","collected_at":"2026-11-03"},{"value":"CME webcast faculty, Clinical Tipping Points in Portal Hypertension","source_url":"https://www.chronicliverdisease.org/webcasts-detail/clinical-tipping-points-in-portal-hypertension-virtual-broadcast-1","status":"provisional","collected_at":"2026-11-03"},{"value":"Webinar speaker for the Hepatitis B Foundation (Yale Viral Hepatitis Program director)","source_url":"https://www.facebook.com/hepbfoundation/posts/upcoming-webinar-join-the-hepatitis-b-foundation-and-liver-cancer-connect-for-ma/1609871084513330/","status":"provisional","collected_at":"2026-11-03"}]},"public_positions":{"total":1,"shown":1,"rows":[{"value":"Authored a comment on the tobevibart-elebsiran SOLSTICE phase 2 hepatitis D trial, listing Joseph.Lim@yale.edu","source_url":"https://tgh.amegroups.org/article/view/10614/html","status":"provisional","collected_at":"2026-11-03"}]}},"similar":[{"name":"Harlan Krumholz","slug":"harlan-krumholz","institution":"Yale School of Medicine","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/harlan-krumholz","json_url":"https://www.findmykol.com/kol/harlan-krumholz/profile.json"},{"name":"Eric Winer","slug":"eric-winer","institution":"Yale School of Medicine","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/eric-winer","json_url":"https://www.findmykol.com/kol/eric-winer/profile.json"},{"name":"Roy Herbst","slug":"roy-herbst","institution":"Yale School of Medicine","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/roy-herbst","json_url":"https://www.findmykol.com/kol/roy-herbst/profile.json"},{"name":"Robert Rosenheck","slug":"robert-rosenheck","institution":"Yale School of Medicine","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/robert-rosenheck","json_url":"https://www.findmykol.com/kol/robert-rosenheck/profile.json"},{"name":"Charles Rice","slug":"charles-rice","institution":"The Rockefeller University","specialty":"Gastroenterology","url":"https://www.findmykol.com/kol/charles-rice","json_url":"https://www.findmykol.com/kol/charles-rice/profile.json"},{"name":"Edward Loftus","slug":"edward-loftus","institution":"Mayo Clinic Rochester","specialty":"Gastroenterology","url":"https://www.findmykol.com/kol/edward-loftus","json_url":"https://www.findmykol.com/kol/edward-loftus/profile.json"},{"name":"Naga Chalasani","slug":"naga-chalasani","institution":"Indiana University School of Medicine","specialty":"Gastroenterology","url":"https://www.findmykol.com/kol/naga-chalasani","json_url":"https://www.findmykol.com/kol/naga-chalasani/profile.json"},{"name":"Bruce Sands","slug":"bruce-sands","institution":"Icahn School of Medicine at Mount Sinai","specialty":"Gastroenterology","url":"https://www.findmykol.com/kol/bruce-sands","json_url":"https://www.findmykol.com/kol/bruce-sands/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":2,"publications":16,"network":37}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-11-03"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-11-03"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 to 2024","collected_at":"2026-11-03"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year","collected_at":"2026-11-03"},"congress":{"name":"OpenAlex","url":"https://openalex.org","provides":"DOI-verified congress abstracts across AACR, ASCO, ASH, ASTRO, ESMO","disclaimer":"Congress abstracts are published as DOI-bearing journal supplements and attributed via the same ORCID-disambiguated authorship as publications.","collected_at":"2026-11-03"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-11-03"}},"methodology_url":"https://www.findmykol.com/about#methodology"}